← 返回

TIL(肿瘤浸润淋巴细胞)预测泰国远端胆管癌预后的意义

英文原题:Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand.

查看英文原题

Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand.

PubMed 2022/12/13(内容时间) Front Oncol Q2 · IF 3.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

远端胆管癌(dCCA)患者通常因就诊和诊断较晚而预后不佳。因此,预测预后的预后因素对于改进治疗策略和改善生活质量至关重要。TIL(肿瘤浸润淋巴细胞)(TILs)已被报道为多种癌症的预后预测因子。

然而,其在 dCCA 中的作用仍不明确。本研究旨在评估 TILs 与 dCCA 患者预后的关联。研究评估了 52 例患者癌症中 TILs 的百分比比例,并以 TIL 中位水平将患者分为两组。进行了生存分析、多因素分析和相关性分析以确定预后因素。

结果显示,低 TIL 水平与较差的生存相关。多因素分析显示 TILs 是不良预后的独立因素。此外,TILs 与生长模式显著相关,两者均被用于对 dCCA 患者进行分类。结合生长模式的 TILs 亚组提高了区分患者预后良好与不良的分层性能。

本研究表明,TILs 可作为预测生存的预后因素,并可用于对 dCCA 患者进行聚类以改善预后判断能力。这一发现可能被纳入泰国 dCCA 分层的新分期系统。

展开英文摘要原文

Patients with distal cholangiocarcinoma (dCCA) generally have poor outcomes because of late presentation and diagnosis.

Therefore, prognostic factors for predicting outcomes are essential to improve therapeutic strategies and quality of life. Tumor-infiltrating lymphocytes (TILs) have been reported as a prognostic predictor in several cancers.

However, their role in dCCA is still unclear. This study aimed to evaluate the association of TILs with outcome in patients with dCCA. Fifty-two patients were evaluated for the percentage rate of TILs in their cancers, and a median TIL level was used to divide the patients into two groups. Survival, multivariate, and correlation analyses were performed to determine the prognostic factors. Results showed that a low TIL level was associated with poor survival. Multivariate analysis revealed TILs as an independent factor for poor outcome.

Moreover, TILs were markedly correlated with growth patterns, and both were applied to classify patients with dCCA. Subgroups of TILs with growth pattern incorporation improved stratification performance in separating good from poor patient outcomes.

This study suggested that TILs could be a prognostic factor for predicting survival and for clustering patients with dCCA to improve prognostication capability. This finding may be incorporated into a new staging system for stratifying dCCA in Thailand.

论文信息

作者
Intarawichian P、Sangpaibool S、Prajumwongs P、Sa-Ngiamwibool P、Sangkhamanon S、Kunprom W、Thanee M、Loilome W
单位
Cholangiocarcinoma Screening and Care Program (CASCAP), Khon Kaen University, Khon Kaen, Thailand.Thailand
期刊
Frontiers in oncology2022
原文标识
PubMed 36582790 · DOI 10.3389/fonc.2022.1004220